FDA NDC Directory · JSON-LD · Markdown

RISPERIDONE

NDC 87564-013 · HUMAN PRESCRIPTION DRUG · TABLET, ORALLY DISINTEGRATING

Labeler / ManufacturerAmerisyn LLC
Marketing categoryAbbreviated NDA (generic) · App ANDA077328
Dosage form / routeTABLET, ORALLY DISINTEGRATING · ORAL
Active ingredientsRISPERIDONE (.5 mg/1)
Marketing started20260806
Package count1

External sources

Source: openFDA. Public-domain (CC0).